Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(3.7)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VRNA Verona Pharma | Maintains: Overweight | 90 100 | 105.8 | -5.48% | 1 | Jun 11, 2025 | |
UTHR United Therapeutics | Initiates Coverage On: Overweight | 405 | 306.48 | 32.15% | 1 | Jun 2, 2025 | |
VNDA Vanda Pharmaceutical... | Assumes: Overweight | 13 | 4.6 | 182.61% | 1 | May 14, 2025 | |
BMRN Biomarin Pharmaceuti... | Reiterates: Overweight | 90 90 | 57.96 | 55.28% | 15 | Feb 20, 2025 | |
VRTX Vertex Pharmaceutica... | Reiterates: Overweight | 480 480 | 394.36 | 21.72% | 22 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 55 | 48.26 | 13.97% | 9 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 80 80 | 118.73 | -32.62% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 591.01 | 71.74% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 296.45 | 36.62% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 458.31 | -52% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 12.01 | -16.74% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 3.97 | 63.73% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 53.07 | 35.67% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | 3.18 | 560.38% | 2 | Feb 23, 2023 |